|
|
|
|
The US FDA has developed a “Long-Term National Strategy to Increase the Resiliency of the US Infant Formula Market” with action points and updated information for stakeholders. The report follows the 2023 Immediate National Strategy release, implemented in response to the 2022 infant formula recall and subsequent product shortages.
|
View more ➜ |
|
|
|
|
Protein and prebiotics specialist FrieslandCampina Ingredients has announced that its lactoferrin ingredient, Vivinal Lactoferrin, is Generally Recognized as Safe (GRAS) for use in cow’s milk-based non-exempt infant formula for term infants and in toddler infant formula in the US.
|
View more ➜ |
|
|
|
|
Discover how Pronativ® by Lactalis Ingredients supports a dietary strategy for healthy aging. Our native whey and micellar casein proteins are at the heart of this approach, offering superior nutritional benefits. Explore our technical paper for detailed insights, recipes and innovative product concepts designed to enhance nutrition and well-being.
|
View more ➜ |
|
|
|
|
In nutrition news, the US FDA denied a request by the Center for Science in the Public Interest (CSPI) to set limits on opiate contamination in poppy seed products, while the Advertising Standards Authority (ASA) decided to uphold child health-centered policies. We look at all of this and more in this week’s edition.
|
View more ➜ |
|
|
|
|
|
NutritionInsight.com is published by
© 2025 CNS Media BV |
|
|
|